JBS N.V. Class A Common Shares vs Onto Innovation — how do they compare? JBS N.V. Class A Common Shares trades at $13 (market cap $13.96B), while Onto Innovation trades at $234.91 (market cap $12.93B). The key difference: JBS N.V. Class A Common Shares and Onto Innovation are close in size by market cap, and JBS N.V. Class A Common Shares pays a 10.31% dividend while Onto Innovation pays none. Which is the better fit depends on your goals — on Pluang, investors hold JBS N.V. Class A Common Shares for 0 Days and Onto Innovation for 7 Days on average.
| JBS | ONTO | |
|---|---|---|
Market Cap | $13.96B | $12.93B |
Volume | 5,326,589 | 1,098,259 |
Sector | Consumer Staples | Technology |
52-Week High | $18.42 | $378.45 |
52-Week Low | $10.86 | $124.09 |
Typical Hold Time | 0 Days | 7 Days |
Enterprise Value | $34.93B | $12.52B |
Dividend Yield | 10.31% | — |
Signals from Pluang's Aura AI — not financial advice
JBS trades at $12.93, up 0.54% today, with a neutral technical signal and strong analyst buy consensus. The stock shows attractive valuation with a P/E of 12.08 and P/S of 0.47, though recent quarterly EPS misses and a declining profit margin to 1.22% in 2026 highlight earnings pressure. Recent news includes a proposal to acquire full control of Pilgrim's Pride and a joint venture in Southeast Asia, indicating strategic expansion.
The outlook is mixed: analyst targets suggest ~40% upside to $18.17, but risks include execution on acquisitions, margin compression, and volatile beef markets. Cash flow turned positive in 2026 projections, supporting growth initiatives, yet debt levels and competitive pressures warrant caution for investors seeking stability.
ONTO trades at $263.55, down 3.72% with bearish technical signals but strong analyst support. The stock shows mixed earnings performance with a Q2 2026 beat but misses in prior quarters. Revenue grew to $1.01B in 2025 with 11.84% net margin, though valuation remains elevated at P/E 98.71. Recent news highlights a $1.1B backlog and strategic partnerships in semiconductor manufacturing.
Outlook remains positive with 100% analyst buy ratings and $387 consensus target suggesting 47% upside. Key risks include high valuation multiples and semiconductor cycle volatility. Growth catalysts include AI-driven demand and Dragonfly G5 product momentum, though execution on backlog conversion is critical.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
JBS N.V. is a protein-processing company producing beef, pork, poultry, lamb, fish, and plant-based products, headquartered in São Paulo and Amsterdam. It operates more than 250 production facilities across over 16 countries under brands including Friboi, Seara, Swift, and Pilgrim's, and is the majority shareholder of Pilgrim's Pride Corporation.
Read more on JBS →Onto Innovation provides process control solutions for semiconductor manufacturing. Its inspection and metrology systems help chipmakers measure, analyze, and detect defects on wafers and advanced packages.
Read more on ONTO →